AU2003252291A1 - Use of disease-associated gene - Google Patents
Use of disease-associated geneInfo
- Publication number
- AU2003252291A1 AU2003252291A1 AU2003252291A AU2003252291A AU2003252291A1 AU 2003252291 A1 AU2003252291 A1 AU 2003252291A1 AU 2003252291 A AU2003252291 A AU 2003252291A AU 2003252291 A AU2003252291 A AU 2003252291A AU 2003252291 A1 AU2003252291 A1 AU 2003252291A1
- Authority
- AU
- Australia
- Prior art keywords
- disease
- associated gene
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-225596 | 2002-08-02 | ||
JP2002225596 | 2002-08-02 | ||
JP2003032807 | 2003-02-10 | ||
JP2003-032807 | 2003-02-10 | ||
JP2003163676A JP2004290170A (ja) | 2002-08-02 | 2003-06-09 | 疾患関連遺伝子の用途 |
JP2003-163676 | 2003-06-09 | ||
PCT/JP2003/009750 WO2004013174A1 (ja) | 2002-08-02 | 2003-07-31 | 疾患関連遺伝子の用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003252291A1 true AU2003252291A1 (en) | 2004-02-23 |
Family
ID=31499106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003252291A Abandoned AU2003252291A1 (en) | 2002-08-02 | 2003-07-31 | Use of disease-associated gene |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2004290170A (ja) |
AU (1) | AU2003252291A1 (ja) |
WO (1) | WO2004013174A1 (ja) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057190A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
CA2426588A1 (en) * | 2000-10-26 | 2002-07-18 | Curagen Corporation | Novel human proteins, polynucleotides encoding them and methods of using the same |
US20030087250A1 (en) * | 2001-03-14 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
US20050033018A1 (en) * | 2001-05-18 | 2005-02-10 | Lal Preeti G. | Receptors and membrane-associated proteins |
-
2003
- 2003-06-09 JP JP2003163676A patent/JP2004290170A/ja not_active Withdrawn
- 2003-07-31 AU AU2003252291A patent/AU2003252291A1/en not_active Abandoned
- 2003-07-31 WO PCT/JP2003/009750 patent/WO2004013174A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004013174A1 (ja) | 2004-02-12 |
JP2004290170A (ja) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1085244A1 (en) | Quantification of gene expression | |
AU2003303250A1 (en) | Quantification of operational risks | |
AU2003236991A1 (en) | Representations of processes | |
AU2003287254A1 (en) | Inhibition of gene expression using rna interfering agents | |
AU2003222197A1 (en) | Inhibition of rna function | |
AU2003275505A1 (en) | Electowinning of metals | |
AU1548401A (en) | Use of disease-associated gene | |
AU2003234925A1 (en) | TGF-Alpha EXPRESSION INHIBITORS | |
AU2003273640A1 (en) | Autism gene | |
AU2003287300A1 (en) | Identification of diet-regulated disease-associated genes | |
AU2003256931A1 (en) | USES OF CIRCADIAN GENE mPER2 | |
AU2003294705A1 (en) | NtSM GENE | |
GB0223424D0 (en) | Disease-associated gene | |
AU2003282564A1 (en) | Gene profiling of single or multiple cells | |
AU2003252291A1 (en) | Use of disease-associated gene | |
AU2003261911A1 (en) | Use of disease-associated gene | |
AU2003238034A1 (en) | Novel use of imidazotriazinones | |
AU2001267885A1 (en) | Use of disease-associated gene | |
AU2002315776A1 (en) | Use of disease-associated gene | |
AU2003277902A1 (en) | Acc gene | |
EP1573055A4 (en) | GENETIC DIAGNOSIS OF DEPRESSION | |
AU2003302457A1 (en) | Mammalian prickle gene | |
AU2003213601A1 (en) | Case hardening of titanium | |
EP1669452A4 (en) | PROMOTER OF THE SYNOVIOLIN GENE | |
AU2003240450A1 (en) | Manufacture of ketopantolactone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |